⚠ LIVE — European Consumer Safety Watch 💊 Medicines: 18 in last 7 days 🍎 Food: 180 in last 7 days 🧸 Products: 48 in last 7 days 🟢 Monitoring: EMA · RASFF · NVWA · FAGG · FAVV · EFSA · Safety Gate ⏱ Last fetch: 3 hours ago ⚠ LIVE — European Consumer Safety Watch 💊 Medicines: 18 in last 7 days 🍎 Food: 180 in last 7 days 🧸 Products: 48 in last 7 days 🟢 Monitoring: EMA · RASFF · NVWA · FAGG · FAVV · EFSA · Safety Gate ⏱ Last fetch: 3 hours ago
🛡️ EUSW
💊 Medicines 🍎 Food 🧸 Products 🔎 Search
📊 Data
🏷 Brands 🌍 Countries ℹ️ About ✉ Unsubscribe
🇬🇧
🇬🇧 English 🇳🇱 Nederlands 🇫🇷 Français 🇩🇪 Deutsch 🇪🇸 Español 🇮🇹 Italiano 🇵🇹 Português 🇵🇱 Polski 🇸🇪 Svenska 🇷🇴 Română 🇨🇿 Čeština 🇫🇮 Suomi 🇩🇰 Dansk
💊 Medicine AT April 22, 2026

Buprenorphin ratiopharm 10 Mikrogramm/h transdermales Pflaster 10 Mikrogramm/h (transdermales Pflaster)

📷 Wikipedia: Buprenorphine · Source
Buprenorphin ratiopharm 10 Mikrogramm/h transdermales Pflaster 10 Mikrogramm/h (transdermales Pflaster)
📷 Wikipedia: Buprenorphine · Source
Parallel export ban in effect. Supply delayed due to manufacturing issues.
⚠️
Shortage ongoing
BUPRENORPHIN is currently in short supply in AT.
📈 Timeline
10 days active so far
May 18, 2026 May 27, 2026

What is this? This is a small sticky patch that gives pain relief. It contains buprenorphine and is worn on the skin.

What's happening? Some packs of this patch are not available right now. Others are still in stock.

Does this affect me? If you use this patch, check if your usual pack is missing.

What should I do? Ask your pharmacist or doctor for help finding another safe option.

🤖 This plain-language summary is automatically generated from the official agency notice using AI. It is for general information only — not medical advice. For decisions about your health, always consult a pharmacist or doctor and read the official source linked below.

🔬 Medical / technical details (for professionals)
Active substance(s)
BUPRENORPHIN
Agency-published detail

🚫 Parallel export ban active · ATC: N02AE01 · Reason: Verzögerung bei der Herstellung · Marketing authorisation holder: Teva B.V., Swensweg 5, 2031 GA Haarlem, Niederlande · Affected packs: 4 Stück Schachtel, Beutel [Nicht verfügbar, since 2026-04-20] · 2 Stück Schachtel, Beutel [verfügbar]

First published
April 22, 2026
Last refreshed by us
15 hours ago
Severity (as classified)
High
Official source
https://medikamente.basg.gv.at/en/medicine-shortage

All information on this page comes from the official agency notice. We translate and summarise it; we don't add or edit facts.

Related alerts

High AT 2 months ago

Buprenorphin ratiopharm 5 Mikrogramm/h transdermales Pflaster 5 Mikrogramm/h (transdermales Pflaster)

Buprenorphin ratiopharm 5 micrograms/h transdermal patch is subject to a parallel export ban.

❓ Frequently asked questions

▸ What is this medicine shortage alert about?
Buprenorphin ratiopharm 10 Mikrogramm/h transdermales Pflaster 10 Mikrogramm/h (transdermales Pflaster). Parallel export ban in effect. Supply delayed due to manufacturing issues.
▸ When was this alert issued?
This alert was issued on April 22, 2026 by BASG (Austria).
▸ Which countries are affected?
The alert applies to Austria.
▸ How serious is this alert?
Serious risk. A serious risk means the product or medicine can cause significant harm. Treat the alert as urgent.
▸ What should I do?
If you take this medicine, contact your pharmacist or prescribing doctor. They can advise on alternative products or substitutes. Do not stop taking prescription medicine without medical advice.
▸ Where can I find the official notice?
The full official notice is published on medikamente.basg.gv.at.

💬 Discussion

Share your experience or ask a question. Real names and email are optional but moderation friendly.

No comments yet — be the first.

We email a confirmation link. Your address stays private.

⚠️ We aggregate official notices. We do not give medical advice. For medical or legal decisions, consult the source agency and a qualified professional.